Alamar Biosciences (ALMR) vs Nautilus Biotechnology (NAUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.80 billion vs $231.6 million), about 7.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | NAUT |
|---|---|---|
| Share price | $25.91 | $1.82 |
| Market cap | $1.80B | $231.60M |
| 1-day change | -6.70% | -7.14% |
| YTD return | — | -6.67% |
| 1-year return | — | +101.77% |
| 5-year return | — | -68.13% |
| EPS (TTM) | $-1.20 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $4.31 |
| 52-week low | $18.85 | $0.82 |
| Distance from 52-week high | -34.59% | -57.77% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +36.63% | +110.44% |
| Average volume | 399.23K | 2.59M |
| Shares outstanding | 69.39M | 127.26M |
| Employees | 286 | 127 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 7.8 times larger than Nautilus Biotechnology by market value ($1.80B vs $231.60M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
ALMR vs NAUT FAQ
Which is bigger, Alamar Biosciences or Nautilus Biotechnology?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.80B compared with $231.60M for Nautilus Biotechnology (NAUT).
Are Alamar Biosciences and Nautilus Biotechnology in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.